Literature DB >> 16012244

The role of human papilloma virus infection in the etiology of oropharyngeal carcinoma.

Liana Puscas1.   

Abstract

PURPOSE OF REVIEW: Evidence is growing that human papilloma virus is responsible for a subset of head and neck carcinomas. This review analyzes the history and current thinking regarding this relatively new etiologic agent of squamous cell carcinoma. RECENT
FINDINGS: Research over the past year has confirmed that human papilloma virus is associated with subset of head and neck squamous cell carcinoma, especially tumors arising from the tonsil. Human papilloma virus 16 is the most common strain found in these tumors. Most studies also indicate that patients with human papilloma virus infection are more likely to have a better prognosis, engage in riskier sexual behavior, and have a history of less tobacco and alcohol consumption than patients who have human papilloma virus-negative tumors. Not all studies confirm these findings, however, and human papilloma virus, even the high-risk strains (16, 18, and 33) are found in a certain percentage of healthy individuals.
SUMMARY: Human papilloma virus (especially strain 16) has been recognized as a probable etiologic agent for some head and neck squamous cell carcinomas. Most commonly, human papilloma virus is associated with tumors arising from the tonsillar epithelium. Because a definitive causal relationship is still to be identified, current research aims to delineate the specific mechanism whereby human papilloma virus produces squamous cell carcinoma. It is hoped that a vaccine may be produced in the near future that will serve as adjuvant therapy for patients with human papilloma virus-positive tumors.

Entities:  

Mesh:

Year:  2005        PMID: 16012244     DOI: 10.1097/01.moo.0000170524.74264.b1

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  4 in total

1.  Survival of patients with HPV-positive oropharyngeal cancer after radiochemotherapy is significantly enhanced.

Authors:  Claudia Lill; Gabriela Kornek; Barbara Bachtiary; Edgar Selzer; Christian Schopper; Martina Mittlboeck; Martin Burian; Friedrich Wrba; Dietmar Thurnher
Journal:  Wien Klin Wochenschr       Date:  2011-03-30       Impact factor: 1.704

Review 2.  Current trends in initial management of oropharyngeal cancer: the declining use of open surgery.

Authors:  Missak Haigentz; Carl E Silver; June Corry; Eric M Genden; Robert P Takes; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-12       Impact factor: 2.503

3.  Vesicular stomatitis virus-based therapeutic vaccination targeted to the E1, E2, E6, and E7 proteins of cottontail rabbit papillomavirus.

Authors:  Janet L Brandsma; Mark Shylankevich; Yuhua Su; Anjeanette Roberts; John K Rose; Daniel Zelterman; Linda Buonocore
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

4.  A 5‑year update of patients with HPV positive versus negative oropharyngeal cancer after radiochemotherapy in Austria.

Authors:  Claudia Lill; Barbara Bachtiary; Edgar Selzer; Martina Mittlboeck; Dietmar Thurnher
Journal:  Wien Klin Wochenschr       Date:  2017-02-15       Impact factor: 1.704

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.